subject area of
- A systematic review of medication safety and clinical outcomes related to drug interaction software. Academic Article
- Adverse Drug Reactions in Canada in 2009–2018: Insights from the Canada Vigilance Database Academic Article
- Adverse Event Assessment of Antimuscarinics for Treating Overactive Bladder: A Network Meta-Analytic Approach Academic Article
- Adverse Events Associated with High-Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome Academic Article
- An updated safety profile of moxifloxacin. Academic Article
- CNODES: the Canadian Network for Observational Drug Effect Studies. Academic Article
- Can current electronic systems meet drug safety and effectiveness requirements? Academic Article
- Community Pharmacy Incident Reporting: A New Tool for Community Pharmacies in Canada Academic Article
- Experience in The Development of a Postmarketing Surveillance Network: The Pharmacy Medication Monitoring Program Academic Article
- Guillain-Barré Syndrome After Influenza Vaccination in Adults Academic Article
- Inhibitor development in haemophilia according to concentrate Academic Article
- Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada Academic Article
- Pharmacovigilance in a genomic era Academic Article
- Phase 4 research: what happens when the rubber meets the road? Academic Article
- Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database Academic Article
- Randomized Trials in Vulnerable Populations Academic Article
- Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding Academic Article
- Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization Academic Article
- SSRI treatment for under-18s Academic Article
- Serious adverse events in academic critical care research Academic Article
- Statin-associated neuromyotoxicity Academic Article
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021 Academic Article
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020 Academic Article
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 Academic Article
- The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 Academic Article